INOVATe (Individualised Ovarian Cancer Treatment Through Integration of Genomic Pathology into Multidisciplinary Care) is a research study that has been established to develop strategies to better define ovarian cancer patient subsets, based on tumour genomic profiling in conjunction with conventional histological subtyping, in an effort to optimise the selection of patients for novel molecularly-targeted clinical trials and ultimately to individualise treatment.

Read more